Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,760
Total Claims
$835K
Drug Cost
339
Beneficiaries
$2,464
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+75%
Cost per patient vs peers
$2,464 vs $1,411 avg
+61%
Brand preference vs peers
17.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.2%
Opioid Rate
197
Opioid Claims
$28K
Opioid Cost
8.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,482 claims · $611K
Generic: 7,202 claims · $221K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 241 | $86K |
| Sitagliptin Phosphate | 84 | $69K |
| Empagliflozin | 59 | $42K |
| Icosapent Ethyl | 94 | $40K |
| Linagliptin | 80 | $35K |
| Linaclotide | 47 | $34K |
| Dulaglutide | 34 | $31K |
| Insulin Aspart | 45 | $27K |
| Dapagliflozin Propanediol | 17 | $18K |
| Dextromethorphan Hbr/Quinidine | 23 | $17K |
| Rivaroxaban | 39 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $15K |
| Memantine Hcl | 165 | $13K |
| Insulin Aspart | 32 | $9,917 |
| Insulin Glargine,hum.Rec.Anlog | 24 | $9,815 |
Prescribing Profile
Patient Profile
79
Avg Age
63%
Female
1.64
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data